en

PRODUCT DETAIL

Otezla 30 mg filmom obalené tablety

Code 3356B
MA number EU/1/14/981/002
Product Form: tbl flm 56x30 mg (blis.PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA32 Apremilast
Shelf life: 36
Container: blister PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 15.01.2015
SmPC + PL: European Medicines Agency's database
Dokument: DHPC_Otezla_7_11_2016.pdf  
Safety feature Yes
Data update: 07.02.2020
eu-flag.png sk-flag.png